Akcea Therapeutics, Inc. Accounts Payable
Akcea Therapeutics, Inc. had Accounts Payable of $4.25 million as of 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2020-08-05
- 2020-06-30: Accounts Payable, Current $4.25M.
- 2020-03-31: Accounts Payable, Current $10.37M.
- 2019-12-31: Accounts Payable, Current $10.22M.
- 2019-09-30: Accounts Payable, Current $5.71M.
| Period end | Accounts Payable, Current |
|---|---|
| 2020-06-30 | $4.25M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $10.37M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $10.22M 10-Q · filed 2020-08-05 |
| 2019-09-30 | $5.71M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $7.94M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $6.15M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $12.07M 10-K · filed 2020-03-02 |
| 2018-09-30 | $3.07M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $2.71M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $2.58M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $2.38M 10-K · filed 2019-03-01 |
| 2017-09-30 | $2.01M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $143.00K 10-Q · filed 2017-08-09 |
| 2016-12-31 | $476.00K 8-K · filed 2018-09-18 |